Biologics / Biotechnology

#Biologics / Biotechnology #Business #Clinical trials #Investment

Ryvu Therapeutics receives €22m to advance cancer portfolio  

Clinical-stage drug discovery company Ryvu Therapeutics has received €22 million from the European Investment Bank (EIB) to help it advance its portfolio of cancer treatments.   The funding, which is being provided under the EIB’s venture debt instrument, will help Ryvu finance its development pipeline of new cancer treatments from discovery… Read More

#Business & Investment #News

Scientist looking through microscope
#Assay #Biologics / Biotechnology #Biopharma #Drug development #Ingredients / APIs / Fine chemicals

Addressing the challenge of salt forms in drug discovery

Listen to this article on the DDW Podcast: Some 5% of commercially available research compounds are sold as salt forms. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability. By selecting the correct salt form for an assay or as a reagent, scientists can optimise… Read More

#Exclusive Content #Opinion

Human brain
#Biologics / Biotechnology #Clinical trials #Drug discovery #Neurology

Calidi Biotherapeutics gets FDA go-ahead for US trial  

Biotechnology company Calidi Biotherapeutics has announced that a Phase I US clinical trial will use the company’s licensed oncolytic virotherapy platform NeuroNova to deliver an oncolytic adenovirus selectively to tumor sites in patients with recurrent high-grade glioma.  The phase I physician-sponsored clinical trial will take place at… Read More

#News

Psilocybin
#Biologics / Biotechnology #Drug discovery #Psychedelics

How this biotech is ramping up its psychedelic drug discovery

Psychedelic plants and fungi have been used medicinally by indigenous populations over thousands of years. But while psychedelic drug research has witnessed a relative roller-coaster ride of effort since the mid-20th century, more recent interest in the use of psychedelics for treating mental health and psychiatric disorders has spurred a… Read More

#Exclusive Content

#Biologics / Biotechnology #Cancer #Oncology #Podcast

Latest DDW podcast: The pursuit of better cancer treatments

This is the latest episode of the free DDW podcast, “The pursuit of better cancer treatments”. It covers two narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. They are called “The personal touch: the scientist making an impact in cancer research” and “Biotech’s pursuit of… Read More

#News

#Biologics / Biotechnology #Manufacturing

BioLamina plans for US expansion  

Biotechnology company BioLamina is targeting a US expansion with plans to open an office in Boston.  The company will open an office in Boston, MA, to help it better support existing and new customers in the US and enable it to collaborate with science hubs in… Read More

#News

#Biologics / Biotechnology #Investment

Redx raises £34m after placement of shares  

Clinical-stage biotech Redx has raised £34 million in funding to help it progress its pipeline of therapeutics targeting cancer and fibrotic disease.   Redx raised the funding through a Bookbuild process in which a company generates investor demand when raising capital in an attempt to achieve the best… Read More

#News

#Biologics / Biotechnology #Biopharma #Investment #LSX World Congress #Supply chain

Comment – pharma trends at LSX World Congress  

The LSX World Congress returned for an in-person event in May, bringing together executives from the biotech, medtech and healthtech sectors, across two days to examine the latest trends across life sciences.  DDW’s Reece Armstrong attended the event – here are the key takeaways from the show.  One of the… Read More

#Exclusive Content #Opinion

London, UK
#Avacta #Biologics / Biotechnology #Pharma

Avacta relocates HQ to London campus   

Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters in London.  The headquarters will be based at Scale Space in Imperial College’s White City Campus, London. Scale Space is part of the broader White City Innovation District. White City is currently… Read More

#News

#Advanced Therapy Medicinal Products (ATMPs) #Biologics / Biotechnology #Events #SLAS Europe

Insight: What to expect from SLAS Europe 2022

Recent OBE recipient and SLAS Europe 2022 keynote speaker Steve Rees tells DDW’s Megan Thomas his thoughts on the themes of SLAS Europe 2022, the value of returning to face-to-face meetings, the influence the organisation has on his work and the industry’s key changes since the SLAS was formed in… Read More

#Exclusive Content

#Biologics / Biotechnology #Hearing Loss #MHRA

Rinri Therapeutics awarded for hearing loss therapy  

Biotechnology company Rinri Therapeutics has been awarded an Innovation Passport by the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) for its cell therapy targeting a form of hearing loss.  The Innovation Passport, which is awarded through the MHRA’s Innovative Licensing and Access Pathway (ILAP), will enable… Read More

#News

#Biologics / Biotechnology #DNA

Evonetix gets patent for gene synthesis method  

Synthetic biology company Evonetix has been granted a European patent covering its unique Binary Assembly method for gene synthesis.  The patent forms part of the company’s plan to simplify gene synthesis for users and enable a new generation of in-lab DNA synthesis platforms.  Evonetix’s novel… Read More

#News

#Biologics / Biotechnology #Clinical trials #Manufacturing #Pharma

This week in drug discovery (2-6 May)   

Swiss biotech sector sees strong performance in 2021, report says  Switzerland’s life sciences sector saw a strong year in 2021 with companies contributing to the Covid-19 pandemic and high levels of capital investments being key indicators of the sector’s strength.   This is according to the… Read More

#News

#AI #Biologics / Biotechnology #Lab automation #SLAS Europe

Using imagination and innovation to bring the scientific world together

Ahead of SLAS Europe May 24-27, 2022, in Dublin, Jill Hronek, SLAS Director, Marketing & Communications, shares how the SLAS community responded to the unprecedented need for laboratory automation internationally, and reflects on the conference theme, ‘Where Imagination Inspires Innovation’. Welcome back to the SLAS Europe Conference and Exhibition; it… Read More

#Exclusive Content